Showing results (81-90 of 535) with videos related to
Sort By:
Pageof 54
The Nursing Clinics of North America|February 3, 2007
Rapid and reversible alterations in thyroid function tests in dehydrated patientsJuan Ybarra, Sandra FernandezRevue De L'Infirmiere|January 20, 2012
[Prevention of risky sexual behavior in psychiatry]Roser Ceinos, Sandra FernandezMethods in Molecular Biology (Clifton, N.J.)|July 9, 2026
Bioinformatics of Shallow Whole Genome Sequencing Data of Circulating Tumor Cells to Inform Cancer Diagnosis and TreatmentMarco Silvestri, Carolina Reduzzi, Cinzia De Marco, et al.Springerplus|October 9, 2013
Presence of anaplastic lymphoma kinase in inflammatory breast cancerFredika M Robertson, Emanuel F Petricoin Iii, Steven J Van Laere, et al.Current Treatment Options in Oncology|July 1, 2019
Emerging Role of Genomics and Cell-Free DNA in Breast CancerLorenzo Gerratana, Andrew A Davis, Ami N Shah, et al.The Oncologist|March 17, 2020
Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer in Young Women: Emerging Data in the Era of Molecularly Targeted AgentsAmi N Shah, Otto Metzger, Cynthia Huang Bartlett, et al.Molecular Cancer Therapeutics|March 6, 2016
Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor ActivityThirupandiyur S Udayakumar, Radka Stoyanova, Mohammed M Shareef, et al.Breast (Edinburgh, Scotland)|April 6, 2025
Mapping breast cancer therapy with circulating tumor cells: The expert perspectiveLorenzo Gerratana, Caterina Gianni, Eleonora Nicolò, et al.The Breast Journal|March 19, 2009
Primary peritoneal serous carcinoma presenting as inflammatory breast cancerIbrahim Khalifeh, Michael T Deavers, Massimo Cristofanilli, et al.Cancer|May 27, 2010
Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4Fredika M Robertson, Ann-Marie Simeone, Anthony Lucci, et al.Pageof 54